EMA — authorised 23 August 2019
- Marketing authorisation holder: La Jolla Pharmaceutical II B.V.
- Status: approved
🇪🇺 Giapreza in European Union
EMA authorised Giapreza on 23 August 2019
Marketing authorisation
Giapreza in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in European Union
Frequently asked questions
Is Giapreza approved in European Union?
Yes. EMA authorised it on 23 August 2019.
Who is the marketing authorisation holder for Giapreza in European Union?
La Jolla Pharmaceutical II B.V. holds the EU marketing authorisation.